Results 31 to 40 of about 5,127,009 (325)

COVID-19 in Older Individuals Requiring Hospitalization

Infectious Disease Reports, 2022
Older individuals have an increased risk for severe coronavirus disease 2019 (COVID-19) and a higher risk for complications and death. The aim of this study was to investigate the clinical characteristics of older patients admitted with COVID-19 and ...
Petros Ioannou, Despoina Spentzouri, Myrto Konidaki, Michalis Papapanagiotou, Sotiris Tzalis, Ioannis Akoumianakis, Theodosios D. Filippatos, Symeon Panagiotakis, Diamantis P. Kofteridis   +8 more
doaj   +1 more source

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Journal of the American Medical Association (JAMA), 2020
Importance There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19). Objective To describe the clinical characteristics and outcomes of patients
Safiya Richardson, J. Hirsch, M. Narasimhan, J. M. Crawford, T. McGinn, K. Davidson, D. Barnaby, L. Becker, J. Chelico, S. Cohen, J. Cookingham, Kevin Coppa, M. Diefenbach, Andrew J. Dominello, J. Duer-Hefele, L. Falzon, J. Gitlin, N. Hajizadeh, Tiffany G Harvin, D. Hirschwerk, Eun Ji Kim, Z. Kozel, Lyndonna M. Marrast, J. Mogavero, Gabrielle A. Osorio, M. Qiu, Theodoros P. Zanos   +26 more
semanticscholar   +1 more source

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

Nature Communications, 2022
Emerging SARS-CoV-2 variants raise concerns on immune evasion. Here, the authors evaluate the neutralization efficiency of COVID-19 mRNA vaccinee sera against representative viruses of 13 WHO-designated SARS-CoV-2 variants of concern/interest.
Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa Mills, Michael Currier, Punya Shrivastava-Ranjan, Brenda M. Calderon, Mili Sheth, Brian R. Mann, Jaber Hossain, Xudong Lin, Sandra Lester, Elizabeth A. Pusch, Joyce Jones, Dan Cui, Payel Chatterjee, M. Harley Jenks, Esther K. Morantz, Gloria P. Larson, Masato Hatta, Jennifer L. Harcourt, Azaibi Tamin, Yan Li, Ying Tao, Kun Zhao, Kristine Lacek, Ashley Burroughs, Wei Wang, Malania Wilson, Terianne Wong, So Hee Park, Suxiang Tong, John R. Barnes, Mark W. Tenforde, Wesley H. Self, Nathan I. Shapiro, Matthew C. Exline, D. Clark Files, Kevin W. Gibbs, David N. Hager, Manish Patel, Alison L. Halpin, Laura K. McMullan, Justin S. Lee, Hongjie Xia, Xuping Xie, Pei-Yong Shi, C. Todd Davis, Christina F. Spiropoulou, Natalie J. Thornburg, M. Steven Oberste, Vivien G. Dugan, SSEV Bioinformatics Working Group, David E. Wentworth, Bin Zhou   +56 more
doaj   +1 more source

Fighting COVID-19 [PDF]

Brazilian Journal of Biology, 2020
Abstract The current COVID-19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and severe forms of respiratory infection. The lack of vaccines and antivirals prevents clinical strategies against the disease, creating an emerging need for the development of safe and effective ...
D. M. O. Campos, C. B. S. Oliveira, J. M. A. Andrade, J. I. N. Oliveira   +3 more
openaire   +6 more sources

Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing

BMC Medicine, 2021
Background Balancing the control of SARS-CoV-2 transmission with the resumption of travel is a global priority. Current recommendations include mitigation measures before, during, and after travel.
Michael A. Johansson, Hannah Wolford, Prabasaj Paul, Pamela S. Diaz, Tai-Ho Chen, Clive M. Brown, Martin S. Cetron, Francisco Alvarado-Ramy   +7 more
doaj   +1 more source

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Annals of Internal Medicine, 2020
Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for ...
S. Lauer, K. Grantz, Qifang Bi, Forrest K. Jones, Qulu Zheng, Hannah R. Meredith, A. Azman, N. Reich, J. Lessler   +8 more
semanticscholar   +1 more source

Performance of existing and novel surveillance case definitions for COVID-19 in household contacts of PCR-confirmed COVID-19

BMC Public Health, 2021
Background Optimized symptom-based COVID-19 case definitions that guide public health surveillance and individual patient management in the community may assist pandemic control. Methods We assessed diagnostic performance of existing cases definitions (e.
Hannah E. Reses, Mark Fajans, Scott H. Lee, Charles M. Heilig, Victoria T. Chu, Natalie J. Thornburg, Kim Christensen, Sanjib Bhattacharyya, Alicia Fry, Aron J. Hall, Jacqueline E. Tate, Hannah L. Kirking, Scott A. Nabity, The U.S. COVID-19 Household Investigation Team   +13 more
doaj   +1 more source

What Is COVID-19?

Frontiers for Young Minds, 2020
COVID-19, the abbreviation for coronavirus disease 2019, is the name of the disease caused by a virus named SARS-CoV-2, an abbreviation for severe acute respiratory syndrome coronavirus 2.
G. Alberca, I. G. Fernandes, Maria Notomi Sato, R. Alberca   +3 more
semanticscholar   +1 more source

Stress Cardiomyopathy in COVID-19 Disease

European Journal of Case Reports in Internal Medicine, 2020
Patients affected by COVID-19 pneumonia may develop stress cardiomyopathy, also known as Takotsubo syndrome (TTS), at different stages during the disease and with different degrees of left ventricular dysfunction.
Maria Cristina Pasqualetto, Eleonora Secco, Manuele Nizzetto, Moreno Scevola, Lorella Altafini, Alberto Cester, Fausto Rigo   +6 more
doaj   +1 more source

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine, 2020
Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
J. Beigel, K. Tomashek, L. Dodd, A. Mehta, B. Zingman, A. Kalil, E. Hohmann, H. Chu, Anne F. Luetkemeyer, S. Kline, Diego López de Castilla, R. Finberg, K. Dierberg, V. Tapson, L. Hsieh, T. Patterson, R. Paredes, D. Sweeney, W. Short, G. Touloumi, D. Lye, N. Ohmagari, M. Oh, G. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M. Kortepeter, R. Atmar, C. Creech, J. Lundgren, A. Babiker, S. Pett, J. Neaton, T. Burgess, Tyler Bonnett, Michelle Green, M. Makowski, A. Osinusi, S. Nayak, H. Lane   +39 more
semanticscholar   +1 more source